Explore over 150 North America-based contract manufacturing organizations engaged in the contract services of manufacturing biologics products including antibodies, vaccines, recombinant products, cell & gene therapy products among others, starting from cell-line development to fill & finish.
The data provides detailed insights that are available nowhere in the market with the goal of assisting market players in advancing their priorities and investments, as well as accessing the competitive landscape.
The data is captured around 25 vital metrics including biologics manufacturer’s name, location, service offering capabilities, scale of manufacturing, technology platforms, products and subproducts manufactured, current & completed projects of CMOs, facility name, location, establishment year, facility size & capacity, annual production, batch size, bioprocessing equipment, bioreactors, expression system, manufacturing process type, regulatory compliance & certifications, sponsors & collaborations, future plans of CMOs and many other parameters. Complete list of parameters is provided in the following section.
High number of biologics manufacturing facilities in the US, makes North America the most dominating globally. The North America CMO market has about 31% of the global CMO capacity with largest segment held by process development service. Some of the key Biologics CMOs covered in this tracker are KBI Biopharma Inc, FloridaBiologix, Cognate BioServices, MassBiologics, Goodwin Biotechnology, VGXI, In, Cytovance Biologics, Inc., and many other key CMOs operating in North America.
The data is underpinned by user-friendly visuals to allow users to filter through within all the parameters to obtain any specific data such as CMOs by country, CMOs name, product manufacturing type, scale of manufacturing, regulatory compliance, bioreactor capacity & types, service offerings, facility size, expression system, manufacturing process mode, analytical and bioprocessing equipment, collaborators, suppliers.